IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach.
about
Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cellsDendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cellsAugmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ.PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice.Confirmation of covalently-linked structure and cell-death inducing activity in site-specific chemical conjugates of human Fas ligand extracellular domain.
P2860
Q33741348-9973599D-8774-49C6-B85F-3497AE55CE85Q33801773-0EB4A2D0-6B5E-4DBF-875F-3F98A37B2E19Q34442600-75A8EB93-486B-409E-B49F-40619E96F60AQ35996208-75D20E11-A3A4-4724-9CA9-5F777C14EC3DQ37238430-186455BF-7C6A-4B5E-B4A1-A1CBB2C67213Q37489634-88AAAD12-83A7-49C9-AF84-DB03631950CAQ38944400-5D9CD45C-3AA5-4833-88A9-A927A6864505Q40314772-7B08A0A9-D989-46A0-AFCC-89E0744919BBQ47728097-9F7FA77D-D5D8-4942-A5A7-058BA30F67B7Q49920174-DAB15ACE-F136-4F28-9F1B-0E950646C95EQ55441897-D92E4A60-06ED-447A-9C2F-56FA9EFA8FBC
P2860
IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@ast
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@en
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@nl
type
label
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@ast
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@en
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@nl
prefLabel
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@ast
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@en
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@nl
P2093
P1433
P1476
IFN-gamma sensitization of pro ...... eath: a gene therapy approach.
@en
P2093
Alexei I Kuzmin
Marcia Meseck
Randy C Eisensmith
Shu-Hsia Chen
Simon J Hall
Steven E Canfield
Waleed A Hassen
William A Selleck
P304
P356
10.1016/S1525-0016(02)00040-0
P577
2003-02-01T00:00:00Z